Alterations in the Growth Factor Signal Transduction Pathways and Modulators of the Cell Cycle in Endocervical Cells from Macaques Exposed to TCDD

Toxicology and Applied Pharmacology

Volumn 151, Issue 2, 1998, Pages 283-293

  Enan, Essam ^a   El Sabeawy, Faten ^a   Scott, Mary ^a   Overstreet, James ^a   Lasley, Bill ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MACACA; PRIMATES;

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; BENZOQUINONE DERIVATIVE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DIOXIN; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELDANAMYCIN; GROWTH PROMOTOR; MACROCYCLIC LACTAM; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOPROTEIN; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; QUINONE DERIVATIVE; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL; ARTICLE; CELL CULTURE; CELL CYCLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; MACACA; METABOLISM; METAPLASIA; PATHOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX;

ANIMALS; BENZOQUINONES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CDC28 PROTEIN KINASE, S CEREVISIAE; CELL CYCLE; CELLS, CULTURED; CERVIX UTERI; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DIOXINS; ENZYME INHIBITORS; FEMALE; GROWTH SUBSTANCES; LACTAMS, MACROCYCLIC; MACACA; METAPLASIA; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; QUINONES; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032135556     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8470     Document Type: Article

References (72)

1. Angel, P., Poting, A., Mallick, U., Rahmsdorf, H. J., Schorpp, M., and Herrlich, P. (1986). Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol. Cell. Biol. 6, 1760-1766.
2. Angel, P., Hattori, K., Smeal, T., and Karin, M. (1988). The Jun protooncogene is positively autoregulated by its product Jun/AP1. Cell 55, 875-885.
3. Barbacid, M. (1986). Involvement of ras oncogene in the inhibition of carcinogen induced tumors. Princess Takamatsu Symposia 17, 43-53.
4. Bohmann, D., Bos, T. J., Admon, A., Nishimura, T., Vogt, P. K., and Tijian, R. (1987). Human proto-oncogene c-jun encodes DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238, 1386-1392.
5. Bombick, D. W., Jankun, J., Tullis, K., and Matsumura, F. (1988). 2,3,7,8-tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc. Natl. Acad. Sci. USA 85, 4128-4132.
6. Brenner, D. A., Ottara, M., Angel, P., Chojker, M., and Karin, M. (1989). Prolonged activation of Jun and collagenase. Nature 337, 661-663.
7. Brinton, L. A. (1992). Epidemiology of cervical cancer-overview. Irac Scientific Publications 119, 3-23.
8. Brinton, L. A., and Fraumeni, J. F. J. (1986). Epidemiology of uterine cervical cancer. J. Chronic Dis. 39, 1051-1065.
9. Burghardt, E. (1993). Natural history, diagnosis and treatment of microinvasive cervical cancer. Pathol. Biol. 41, 66.
10. Crook, T., Wrede, D., and Vousden, K. H. (1991). P53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6, 873-875.
11. Crook, T., and Vousden, K. H. (1992). Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J. 11, 3935-3940.
12. Denison, M. S., Cuthil, A-C., Wilkstrom, L., Poellinger, L., Gustafsson, J. A. (1988). Association of the dioxin receptor with the Mr90,000 heat shock protein, Biochem. Biophys. Res. Commun. 155, 801-807.
13. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994). JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
14. Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992). The mammalian ultraviolet response is triggered by activation by Scr tyrosine kinases. Cell 71, 1081-1091.
15. Enan, E., and Matsumura, F. (1994). Significance of TCDD-induced in protein phosphorylation in the adipocyte of male guinea pigs. J. Biochem. Toxicol. 9, 159-170.
16. Enan, E., and Matsumura, F. (1995a). Evidence for a second pathway in the action mechanism of TCDD: Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49, 249-261.
17. Enan, E., and Matsumura, F. (1995b). Regulation of AP-1 activity by TCDD through nuclear protein phosphorylation in adipose tissue of guinea pig. Biochem. Pharmacol. 50, 1199-1206.
18. Enan, E., and Matsumura, F. (1996). Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol. 52, 1599-1612.
19. Enan, E., Lasley, B. L., Stewart, D. R., Overstreet, J. W., and VandeVoort, C. A. (1996a). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) modulates function of human luteinizing granulosa cells via cAMP signalling and early reduction of glucose transporting activity. Reprod. Toxicol. 10, 191-198.
20. Enan, E., Moran, F., VandeVoort, C. A., Stewart, D. R., Overstreet, J. W., and Lasley, B. L. (1996b). Mechanism of toxic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in cultured human luteinizing granulosa cells. Reprod. Toxicol. 10, 497-508.
21. Enan, E., El-Sabeawy, F., Moran, F., Overstreet, J. W., and Lasley, B. L. (1997). Interruption of estradiol signal transduction by TCDD through disruption of the protein phosphorylation pathway in adipose tissues from immature and mature female rats. Biochem. Pharmacol. 55, 1077-1090.
22. Fukasawa, K., and Vande Woude, G. F. (1997). Synergy between the Mos/ mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol. Cell. Biol. 17, 506-518.
23. Gopas, J., Ono, M., Princler, G., Smith, M. R., Tainsky, M. A., et al. (1992). EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells. Cell. Mol. Biol. 38, 605-614.
24. Hembree, J., Agarwal, C., and Eckert, R. L. (1994). Epidermal growth factor suppresses insulin-like growth factor binding protein-3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of IGF-I. Cancer Res. 54, 3160-3166.
25. Hendrickx, A. G., Dieter, J., Lasley, B. L., Stewart, D. R., Tarantal, A. F., and Overstreet, J. W. (1997). Biomarkers of early fetal loss in macaques: TCDD as a model of environmental toxicity. Submitted for publication.
26. Herschman, H. R. (1991). Primary response genes induced by growth factors and tumor promotors. Annu. Rev. Biochem. 60, 281-319.
27. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993). Identification of an oncoprotein- and UV-responsive protein. Kinase that binds and potentiates the c-jun activation domain. Genes Dev. 7, 2135-2148.
28. Hoekstra, M. F., Liskay, R. M., Ou, A. C., Demaggio, A. J., Byrbee, D. G., and Heffron, F. (1991). Hrr25, a putative protein kinase from budding yeast: Association with repair of damaged DNA. Science 253, 1031-1034.
29. Hudson, L. G., Toscano, W. A., and Greenlee, W. F. (1985). Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 77, 251-259.
30. Imbra, R. J., and Karin, J. (1987). Metallothione gene expression is regulated by serum factors and activators of protein kinase. Mol. Cell. Biol. 7, 1358-1363.
31. Kageyama, R., and Pastan, I. (1989). Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell 59, 815-825.
32. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Derijard, B., Moore, G., Davis, R., and Karin, M. (1994). JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007.
33. Karenlampi, S. O., Eisen, H. J., Hankinson, O., Nebert, D. W. (1983). Effects of cytochrome P1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma. J. Biol. Chem. 258, 10378-10383.
34. Karin, M. (1991). Signal transduction and gene control. Current opinion. Cell Biol. 3, 467-473.
35. Karin, M. (1996). The regulation of AP-1 activity by mitogen-activated protein kinases. Biol. Sci. 351, 127-134.
36. Kawamoto, T., Matsumura, F., Madhukar, D. V., Bombick, D. W. (1989). Effects of TCDD on the EGF receptor of XB mouse keratinizing epithelial cell. J. Biochem. Tox. 4, 173-182.
37. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
38. Lees-Miller, S. P., Chen, Y. R., and Anderson, C. W. (1990). Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40T antigen, mouse p53 and human Ku auto antigen. Mol. Cell. Biol. 10, 6472-6481.
39. Lin, A., Forst, J., Deng, T., Smeal, S., Al-Alwai, N., Kikkawa, M., Hunter, T., Benner, D., and Karin, M. (1992). Casein kinase II is a negative regulator of c-jun DNA binding and AP-1 activity. Cell 70, 777-789.
40. Lowy, D. R., Kirnbauer, R., and Schiller, J. T. (1994). Genital human papillomavirus infection. Proc. Natl. Acad. Sci. USA 91, 2436-2440.
41. Ma, X., and Babish, J. D. (1993). Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent inases. Biochem. Biophys. Res. Comm. 197, 1070-1077.
42. Madhukar, B. V., Ebner, K., Matsumura, F., Bombick, D. W., Brewster, D. W., Kawamoto, T. (1988). 2,3,7,8-tetrachlorodibenzo-p-dioxin causes an increase in protein kinases associated with epidermal growth factor receptor in the hepatic plasma membrane. J. Biochem. Toxicol. 3, 261-277.
43. Matsumura, F., Brewster, D. W., Madhukar, B. V., and Bombick, D. W. (1984). Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Arch. Environ. Contam. Toxicol. 13, 509-515.
44. Matsumura, F., Madhukar, B. V., Bombick, D. W., and Brewster, D. W. (1985). Toxicological significance of pleiotropic changes of plasma membrane functions particularly that of EGF receptor caused by 2,3,7,8-TCDD. Banbury Report 18: Biological mechanisms of dioxin action. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
45. Meek, D., Simon, S., Kikkawa, M., and Eckhart, W. (1990). The p53 tumor suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 9, 3253-3260.
46. Meek, D. W., and Street, A. J. (1992). Nuclear protein phosphorylation and growth control. Biochem. J. 287, 1-15.
47. Mercer, W. E., Shields, M. T., Amin, M., Savve, G. J., Appella, E., Romano, J. W., and Ullrich, S. J. (1990). Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA 87, 6166-6170.
48. Monticello, T. M., Barton, D., Ma, X., Babish, J. D., and Durham, S. K. (1995). Comparison of acute hepatocellular proliferating cell nuclear antigen labeling indices and growth fractions, p34cdc2 kinases, and serum enzymes in carbon tetrachloride-treated rats. Toxicol. Pathol. 23, 439-446.
49. Moriya, M., Matsumura, F., and Kalim, G. (1986). 2,3,7,8-Tetrachlorodibenzo-p-dioxin reduces high affinity binding to epidermal growth factor to cell surface receptors in C 10+ 1/2 cells. J. Biochem. Toxicol. 1, 45-54.
50. Okimoto, T., Kohne, K., Kuwanao, M., Gopas, J., and King, H. (1996). Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: Possible roles of AP-1. Oncogene 12, 1625-1633.
51. Parkin, D. M., Larra, E., and Muir, C. S. (1988). Estimates of the worldwide frequency of sixteen major cancers in 1980. Int. J. Cancer 41, 184-197.
52. Rauscher, F. J., III, Sambucetti, L. C., Curran, T., Distel, R. J., and Spiegelman, B. M. (1988). Common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell 52, 471-480.
53. Rininger, J. A., Wheelock, G. D., Ma, X., and Babish, J. D. (1996). Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthiol] acetic acid (WY14,643). Biochem. Pharmacol. 52, 1749-1755.
54. Rininger, J. A., Stoffregen, D. A., and Babish, J. G. (1997). Murine hepatic p53, RB and CDK inhibitory protein expression following acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. Chemosphere 34, 1557-1568.
55. Rowles, J., Slaughter, C., Moomaw, C., Hsu, J., and Cobb, M. H. (1991). Purification of casein kinase I and isolation of cDNAs encoding multiple casein I-like enzymes. Proc. Natl. Acad. Sci. USA 88, 9548-9552.
56. Rusch, V., Klimstra, D., Linkov, I., and Dmitrovsky, E. (1995). Aberant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamores cell carcinoma development. Cancer Res. 55, 1365-1372.
57. Scheffner, M., Munger, K., Byren, J. C., and Howley, P. M. (1991). The state of p53 and retinoblastoma gene in human cervical carcinoma line. Proc. Natl. Acad. Sci. USA 88, 5523-5527.
58. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levin, A. J., and Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
59. Scheidtmann, K. H., Mumby, M., Rundell, K., and Walter, G. (1991). Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: Inhibition by small-t antigen. Mol. Cell. Biol. 11, 1996-2003.
60. Schonlthal, A., Herrlich, P., Rahmsdorf, H. J., and Ponta, H. (1988). Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54, 325-334.
61. Schutte, J., Minn, J. D., and Birren, M. J. (1989b). Deregulated expression of human c-Jun transforms primary rat embryo cells in cooperation with an activated C-Ha-ras gene and transforms rat 1a cells as a single gene. Proc. Natl. Acad. Sci. USA 86, 2257-2261.
62. Schutte, J., Viallet, J., Nau, M., Segal, S., Fedorko, J., and Minna, J. (1989a). Jun-B inhibits and C-fos stimulates the transforming and transactivating activities of c-Jun. Cell 59, 987-997.
63. Scott, M. A., Tarara, R. P., Hendricks, A. G., Benirschke, K., Overstreet, J. W., and Lasley, B. L. (1998). Exposure to the dioxin 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces squamous metaplasia in the endocervix of cynomolgus macaques. Submitted for publication.
64. Shaw, P., Bovey, R., Trady, S., Sordat, B., and Costa, J. (1992). Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89, 4495-4499.
65. Steller, M. A., Delgado, C. H., and Zou, Z. (1995). Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells. Proc. Natl. Acad. Sci. USA 92, 11970-11974.
66. Sturzbecher, H. W., Montenarh, M., and Hennings, R. (1987). Enhanced protein phosphorylation in SV40-transformed and infected cells. Virology 160, 445-455.
67. Ullrich, A., Schlessinger, Y. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
68. Wasylyk, C., Imler, J. L., and Wasylyk, B. (1988). Transforming but not immortalizing oncogenes activate transcription factor PEA1. EMBO J. 7, 2475-2483.
69. Werness, B. A., Levine, A. J., and Howley, P. M. (1989). Association of human papillomavirus types 16 and 18 E6 patients with p53. Science 248, 76-79.
70. Westwick, J. K., Weitzel, C., Leffert, H. L., and Brenner, D. A. (1995). Activation of Jun kinase is an early event in hepatic regeneration. J. Clin. Invest. 95, 803-810.
71. Yamaki, H., Nakajima, M., Seimiya, H., Saya, H., Sugita, M., and Tsuruo, T. (1995). Inhibition of the association with nuclear matrix of pRB, p70 and p40 proteins along with the specific suppression of c-MYC expression by geldanamycin, an inhibitor of sere tyrosine kinase. J. Antibiot. 48, 1021-1026.
72. Zheng, P. S., Iwasaka, T., Ouchida, M., Fukuda, K., Yokoyama, M., and Sugimari, H. (1996). Growth suppression of cervical cancer cell line (TMCc-1) by human wild-type p53 gene. Gynecol. Oncol. 60, 245-250.